COMPANION ANIMAL VACCINE MARKET ANALYSIS

Companion Animal Vaccine Market, By Product Type (Attenuated Live Vaccine, Conjugate Vaccine, Inactivated Vaccine, Subunit Vaccine, Toxoid Vaccine, DNA Vaccine, Recombinant Vaccine), By Species Type (Canine, Feline, Equine, Avians, and Others) , By Distribution Channel (Veterinary Clinics, Veterinary Hospitals, Veterinary Research Institutes and Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Global Companion Animal Vaccine Market : Key Developments

In September 2022 Merck Animal Health announced the donation of five million doses of its NOBIVAC rabies vaccine to help eliminate canine-mediated rabies through the Afya program. Mission Rabies has now vaccinated nearly two million dogs through Merck Animal Health’s Afya program.
In July 2020, Elanco, a U.S.-based animal health and pharmaceutical company, announced the acquisition of Bayer’s animal health division, a German-based healthcare company, for $7.6 billion to expand its animal healthcare portfolio.
In April 2020, Boehringer Ingelheim, a U.K. company, collaborated with VetHelpDirect, which offered all U.K. veterinary practices free access to an online video consultation platform for a period of three months during the pandemic. By offering an alternative to face-to-face consultation, the online platform is a means of continuing care for animals while protecting both clients and staff from the spread of COVID-19.
In October 2020, Zoetis, a global animal health company, announced the launch of Versican Plus Bb Oral, the first oral vaccine for dogs in Europe. The vaccine provides robust, long-lasting protection against Bordetella bronchiseptica, a primary component of the canine infectious respiratory disease complex (CIRDC), with easy oral administration.